CRISPR Engineering of Bacteriophage T4 to Design Vaccines Against SARS-CoV-2 and Emerging Pathogens
- 17 December 2021
- book chapter
- protocol
- Published by Springer Science and Business Media LLC
- Vol. 2410, 209-228
- https://doi.org/10.1007/978-1-0716-1884-4_10
Abstract
The COVID-19 pandemic brought to the fore the urgent need for vaccine design and delivery platforms that can be rapidly deployed for manufacture and distribution. Though the mRNA and adenoviral vector platforms have been enormously successful to control SARS-CoV-2 viral infections, it is unclear if this could be replicated against more complex pathogens or the emerging variants. Recently, we described a “universal” platform that can incorporate multiple vaccine targets into the same nanoparticle scaffold by CRISPR engineering of bacteriophage T4. A T4-COVID vaccine designed with this technology elicited broad immunogenicity and complete protection against virus challenge in a mouse model. Here, we describe the detailed methodology to generate recombinant bacteriophage T4 backbones using CRISPR that can also be broadly applicable to other bacteriophages that abundantly pervade the Earth.Keywords
This publication has 37 references indexed in Scilit:
- Immunological Principles Guiding the Rational Design of Particles for Vaccine DeliveryACS Nano, 2017
- Structure, Function, and Evolution of Coronavirus Spike ProteinsAnnual Review of Virology, 2016
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editingNature Methods, 2013
- Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague VaccinesPLoS Pathogens, 2013
- In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machineProceedings of the National Academy of Sciences of the United States of America, 2013
- Structure of the Three N-Terminal Immunoglobulin Domains of the Highly Immunogenic Outer Capsid Protein from a T4-Like BacteriophageJournal of Virology, 2011
- Assembly of the Small Outer Capsid Protein, Soc, on Bacteriophage T4: A Novel System for High Density Display of Multiple Large Anthrax Toxins and Foreign Proteins on Phage CapsidJournal of Molecular Biology, 2007
- Multicomponent anthrax toxin display and delivery using bacteriophage T4Vaccine, 2007
- Molecular architecture of the prolate head of bacteriophage T4Proceedings of the National Academy of Sciences of the United States of America, 2004
- The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitroJournal of Molecular Biology, 1977